Showing 2451-2460 of 7169 results for "".
An atypical presentation of unilateral, linear, hypertrophic lichen planus in a Patient with HIV
https://practicaldermatology.com/youngmd-connect/resident-resource-center/an-atypical-presentation-of-unilateral-linear-hypertrophic-lichen-planus-in-a-patient-with-hiv/20875/Seeing the Spectrum: Recognizing Lichen Planus in Various Skin Types
https://practicaldermatology.com/youngmd-connect/resident-resource-center/seeing-the-spectrum-recognizing-lichen-planus-in-various-skin-types/23393/How Lichen Planus presents in various skin types and tips on differential diagnosis.Leadership Without Authority:Influencers of Culture in Your Practice
https://practicaldermatology.com/issues/may-june-2025/leadership-without-authority-influencers-of-culture-in-your-practice/35924/Influencers in popular culture demonstrate how individuals without formal authority can shape trends, ideas, and behavior.Angioleiomyoma in a Rare Location
https://practicaldermatology.com/topics/other-dermatology/angioleiomyoma-in-a-rare-location/24012/A minimally invasive treatment is used to treat a tumor in a cosmetically sensitive area.Pharma Sales 2.0
https://practicaldermatology.com/topics/practice-management/pharma-sales-20/23959/A behind-the-scenes look at how ReachRX aims to transform pharma sales and boost patient access.Physician Spotlight With Latanya Benjamin, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-with-latanya-benjamin-md/23950/Physician Spotlight: Meena Singh, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-meena-singh/23939/Should You Hire a Scribe?
https://practicaldermatology.com/topics/practice-management/should-you-hire-a-scribe/23923/What to consider before bringing a scribe into your practice and the benefits of doing so.When Our Health Care System Injures the Physician’s Soul
https://practicaldermatology.com/topics/practice-management/when-our-health-care-system-injures-the-physicians-soul/23845/One dermatologist’s quest to protect physicians from moral injury.DermWireTV: Zoryve Approved; New SDPA President; Project Determi-Nation; Stelara for Pediatric PsA
https://practicaldermatology.com/topics/psoriasis/dermwiretv-zoryve-approved-new-sdpa-president-project-determi-nation-stelara-for-pediatric-psa/20115/FDA has approved Zoryve from Arcutis Biotherapeutics for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. The novel formulation of roflumilast cream 0.3% is indicated for once-daily application. Stelara (ustekinumab) from Janssen is now approve